A detailed history of Hilton Capital Management, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Hilton Capital Management, LLC holds 25,510 shares of IOBT stock, worth $20,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,510
Holding current value
$20,918
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$0.36 - $2.4 $9,183 - $61,224
25,510 New
25,510 $9,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $23.6M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Hilton Capital Management, LLC Portfolio

Follow Hilton Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilton Capital Management, LLC with notifications on news.